Morgan Stanley Grifols Sa Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Grifols Sa stock. As of the latest transaction made, Morgan Stanley holds 2,454,910 shares of GRFS stock, worth $21.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,454,910

Previous 1,578,245 55.55%

Holding current value

$21.4 Million

Previous $11.7 Million 48.65%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$6.62 - $8.71 $5.8 Million - $7.64 Million	876,665 Added 55.55%	2,454,910 $17.5 Million
Q4 2024 Feb 14, 2025	SELL	$6.99 - $9.55 $6.14 Million - $8.39 Million	-878,030 Reduced 35.75%	1,578,245 $11.7 Million
Q3 2024 May 14, 2025	SELL	$6.28 - $9.38 $3.34 Million - $4.99 Million	-532,076 Reduced 17.81%	2,456,275 $21.8 Million
Q3 2024 Nov 14, 2024	SELL	$6.28 - $9.38 $3.34 Million - $4.99 Million	-532,076 Reduced 17.81%	2,456,275 $21.8 Million
Q2 2024 May 14, 2025	BUY	$6.27 - $7.7 $8.84 Million - $10.9 Million	1,410,106 Added 89.35%	2,988,351 $18.8 Million
Q2 2024 Oct 17, 2024	BUY	$6.27 - $7.7 $6.87 Million - $8.44 Million	1,095,961 Added 57.91%	2,988,351 $18.8 Million
Q2 2024 Aug 14, 2024	BUY	$6.27 - $7.7 $6.87 Million - $8.44 Million	1,095,961 Added 57.91%	2,988,351 $18.8 Million
Q1 2024 Oct 17, 2024	SELL	$5.47 - $11.38 $5.99 Million - $12.5 Million	-1,095,961 Reduced 36.67%	1,892,390 $12.6 Million
Q1 2024 Aug 16, 2024	SELL	$5.47 - $11.38 $6 Million - $12.5 Million	-1,096,755 Reduced 36.69%	1,892,390 $12.6 Million
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $6 Million - $12.5 Million	-1,096,755 Reduced 36.69%	1,892,390 $12.6 Million
Q4 2023 Aug 16, 2024	BUY	$7.71 - $11.56 $6,121 - $9,178	794 Added 0.03%	2,989,145 $34.6 Million
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $6.54 Million - $9.81 Million	848,280 Added 39.62%	2,989,145 $34.6 Million
Q3 2023 Nov 15, 2023	BUY	$8.91 - $10.91 $2.04 Million - $2.49 Million	228,658 Added 11.96%	2,140,865 $19.6 Million
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $490,875 - $638,687	68,750 Added 3.73%	1,912,207 $17.5 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $102,922 - $165,449	15,477 Added 0.85%	1,843,457 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $2.26 Million - $3.23 Million	379,156 Added 26.17%	1,827,980 $15.5 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $12.9 Million - $30.9 Million	-2,162,916 Reduced 59.89%	1,448,824 $8.92 Million
Q2 2022 Oct 27, 2022	BUY	$10.6 - $13.28 $33.6 Million - $42 Million	3,165,095 Added 708.64%	3,611,740 $42.9 Million
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $33.6 Million - $42 Million	3,165,095 Added 708.64%	3,611,740 $42.9 Million
Q1 2022 Oct 27, 2022	SELL	$10.37 - $12.73 $32.8 Million - $40.3 Million	-3,165,095 Reduced 87.63%	446,645 $5.22 Million
Q1 2022 May 13, 2022	SELL	$10.37 - $12.73 $2.42 Million - $2.97 Million	-233,590 Reduced 34.34%	446,645 $5.22 Million
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $3.94 Million - $5.89 Million	-385,504 Reduced 36.17%	680,235 $7.64 Million
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $15 Million - $18.4 Million	1,065,739 New	1,065,739 $15.6 Million

Others Institutions Holding GRFS

# of Institutions

166

Shares Held

153M

Call Options Held

76.5K

Put Options Held

106K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.92B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account